TLR3 and RIG-I gene variants: Associations with functional effects on receptor expression and responses to measles virus and vaccine in vaccinated infants

Human Immunology

Volumn 73, Issue 6, 2012, Pages 677-685

  Clifford, Holly D ^a,b   Yerkovich, Stephanie T ^c   Khoo, Siew Kim ^a,b   Zhang, Guicheng ^a,b   Upham, John ^d   Le Souëf, Peter N ^a,b   Richmond, Peter ^a,b   Hayden, Catherine M ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c THE PRINCE CHARLES HOSPITAL   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; MEASLES MUMPS RUBELLA VACCINE; MEASLES VACCINE; POLYINOSINIC POLYCYTIDYLIC ACID; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 3; VARICELLA ZOSTER VACCINE;

ARTICLE; CELL LYSATE; CHILD; CYTOKINE RESPONSE; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; FLOW CYTOMETRY; GENETIC DIFFERENCE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; HUMAN CELL; IMMUNOGENICITY; INFANT; MALE; MEASLES; MEASLES VIRUS; NONHUMAN; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; VACCINATION; VACCINE FAILURE;

ANTIBODIES, VIRAL; CELLS, CULTURED; DEAD-BOX RNA HELICASES; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION STUDIES; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; INFANT; INTERFERON-BETA; INTERFERON-GAMMA; KILLER CELLS, NATURAL; MALE; MEASLES; MEASLES VIRUS; MEASLES-MUMPS-RUBELLA VACCINE; POLY I-C; POLYMORPHISM, SINGLE NUCLEOTIDE; TOLL-LIKE RECEPTOR 3; VACCINATION;

EID: 84861781059     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2012.03.004     Document Type: Article

References (45)

1. Centers for Disease Control and Prevention (CDC). Global measles mortality, 2000-2008. Wkly Epidemiol Rec 2009;58(47):1321-6.
2. Cutts F.T., Henao-Restrepo A., Olivé J.M. Measles elimination: progress and challenges. Vaccine 1999, 17(Suppl. 3):S47-S52.
3. Brunell P.A., Weigle K., Murphy M.D., Shehab Z., Cobb E. Antibody response following measles-mumps-rubella vaccine under conditions of customary use. JAMA 1983, 250:1409-1412.
4. Gans H., Yasukawa L., Rinki M., Dehovitz R., Forghani B., Beeler J., et al. Immune responses to measles and mumps vaccination of infants at 6, 9, and 12months. J Infect Dis 2001, 184:817-826.
5. Medzhitov R., Janeway C. Innate immune recognition: mechanisms and pathways. Immunol Rev 2000, 173:89-97.
6. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu Rev Immunol 2003, 21:335-376.
7. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 2001, 413:732-738.
8. Tanabe M., Kurita-Taniguchi M., Takeuchi K., Takeda M., Ayata M., Ogura H., et al. Mechanism of up-regulation of human Toll-like receptor 3 secondary to infection of measles virus-attenuated strains. Biochem Biophys Res Commun 2003, 311:39-48.
9. Shingai M., Ebihara T., Begum N.A., Kato A., Honma T., Matsumoto K., et al. Differential type I IFN-inducing abilities of wild-type versus vaccine strains of measles virus. J Immunol 2007, 179(9):6123-6133.
10. Bieback K., Lien E., Klagge I.M., Avota E., Schneider-Schaulies J., Duprex W.P., et al. Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J Virol 2002, 76(17):8729-8736.
11. Schmidt K.N., Leung B., Kwong M., Zarember K.A., Satyal S., Navas T.A., et al. APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J Immunol 2004, 172(1):138-143.
12. Zarember K.A., Godowski P.J. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J Immunol 2002, 168(2):554-561.
13. Sumpter R., Loo Y.M., Foy E., Li K., Yoneyama M., Fujita T., et al. Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase. RIG-I. J Virol 2005, 79(5):2689-2699.
14. Yoneyama M., Kikuchi M., Natsukawa T., Shinobu N., Imaizumi T., Miyagishi M., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004, 5(7):730-737.
15. Berghäll H., Sirén J., Sarkar D., Julkunen I., Fisher P.B., Vainionpää R., et al. The interferon-inducible RNA helicase, mda-5, is involved in measles virus-induced expression of antiviral cytokines. Microbes Infect 2006, 8(8):2138-2144.
16. Dhiman N., Ovsyannikova I.G., Cunningham J.M., Vierkant R.A., Kennedy R.B., Pankratz V.S., et al. Associations between measles vaccine immunity and single-nucleotide polymorphisms in cytokine and cytokine receptor genes. J Infect Dis 2007, 195(1):21-29.
17. Dhiman N., Poland G.A., Cunningham J.M., Jacobson R.M., Ovsyannikova I.G., Vierkant R.A., et al. Variations in measles vaccine-specific humoral immunity by polymorphisms in SLAM and CD46 measles virus receptors. J Allergy Clin Immunol 2007, 120:666-672.
18. Dhiman N., Ovsyannikova I.G., Vierkant R.A., Ryan J.E., Pankratz V.S., Jacobson R.M., et al. Associations between SNPs in toll-like receptors and related intracellular signaling molecules and immune responses to measles vaccine: preliminary results. Vaccine 2008, 26(14):1731-1736.
19. Yerkovich S.T., Rowe J., Richmond P., Suriyaarachchi D., Heaton T., Hollams E., et al. Assessment of the potency and potential immunomodulatory effects of the measles mumps rubella and varicella vaccine in infants. Vaccine 2007, 25:1764-1770.
20. Clifford H.D., Richmond P., Khoo S.K., Zhang G., Yerkovich S.T., Le Souëf P.N., et al. SLAM and DC-SIGN measles receptor polymorphisms and their impact on antibody and cytokine responses to measles vaccine. Vaccine 2011, 29(33):5407-5413.
21. Clifford H.D., Yerkovich S.T., Khoo S.K., Zhang G., Upham J., Le Souëf P.N., et al. Toll-like receptor 7 and 8 polymorphisms: associations with functional effects and cellular and antibody responses to measles virus and vaccine. Immunogenetics 2012, 64(3):219-228.
22. Rowe J., Macaubas C., Monger T., Holt B.J., Harvey J., Poolman J.T., et al. Heterogeneity in diphtheria-tetanus-acellular pertussis vaccine-specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systemic Th1 function. J Infect Dis 2001, 184:80-88.
23. Rowe J., Yerkovich S.T., Richmond P., Suriyaarachchi D., Fisher E., Feddema L., Loh R., Sly P.D., Holt P.G. Th2-associated local reactions to the acellular diphtheria-tetanus-pertussis vaccine in 4- to 6-year-old children. Infect Immun 2005, 73(12):8130-8135.
24. Huang Z., Dry I., Webster D., Strugnell R., Wesselingh S. Plant-derived measles virus hemagglutinin protein induces neutralizing antibodies in mice. Vaccine 2001, 19(15-16):2163-2171.
25. Rowe J., Heaton T., Kusel M., Suriyaarachchi D., Serralha M., Holt B.J., et al. High IFN-gamma production by CD8+ T cells and early sensitization among infants at high risk of atopy. J Allergy Clin Immunol 2004, 113(4):710-716.
26. Towbin H., Schmitz A., Jakschies D., Von Wussow P., Horisberger M.A. A whole blood immunoassay for the interferon-inducible human Mx protein. J Interferon Res 1992, 12(2):67-74.
27. Roers A., Hochkeppel H.K., Horisberger M.A., Hovanessian A., Haller O. MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon. J Infect Dis 1994, 169(4):807-813.
28. Hamalainen H.K., Tubman J.C., Vikman S., Kyrölä T., Ylikoski E., Warrington J.A., et al. Identification and validation of endogenous reference genes for expression profiling of T helper cell differentiation by quantitative real-time RT-PCR. Anal Biochem 2001, 299(1):63-70.
29. Takeda K., Akira S. Toll-like receptors in innate immunity. Int Immunol 2005, 17(1):1-14.
30. Matsumoto M., Funami K., Tanabe M., Oshiumi H., Shingai M., Seto Y., et al. Subcellular localization of Toll-like receptor 3 in human dendritic cells. J Immunol 2003, 171:3154-3162.
31. Cella M., Salio M., Sakakibara Y., Langen H., Julkunen I., Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J Exp Med 1999, 189:821-829.
32. Kato H., Takeuchi O., Sato S., Yoneyama M., Yamamoto M., Matsui K., et al. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 2006, 441(7089):101-105.
33. Theofilopoulos A.N., Baccala R., Beutler B., Kono D.H. Type I interferons (alpha/beta) in immunity and autoimmunity. Annu Rev Immunol 2005, 23:307-336.
34. Honda K., Takaoka A., Taniguchi T. Type I interferon gene induction by the interferon regulatory factor family of transcription factors. Immunity 2006, 25(3):349-360.
35. Hewson C.A., Jardine A., Edwards M.R., Laza-Stanca V., Johnston S.L. Toll-like receptor 3 is induced by and mediates antiviral activity against rhinovirus infection of human bronchial epithelial cells. J Virol 2005, 79(19):12273-12279.
36. Loo Y.M., Fornek J., Crochet N., Bajwa G., Perwitasari O., Martinez-Sobrido L., et al. Distinct RIG-I and MDA5 signaling by RNA viruses in innate immunity. J Virol 2008, 82(1):335-345.
37. Rudd B.D., Burstein E., Duckett C.S., Li X., Lukacs N.W. Differential role for TLR3 in respiratory syncytial virus-induced chemokine expression. J Virol 2005, 79(6):3350-3357.
38. Sarkar S.N., Smith H.L., Rowe T.M., Sen G.C. Double-stranded RNA signaling by Toll-like receptor 3 requires specific tyrosine residues in its cytoplasmic domain. J Biol Chem 2003, 278(7):4393-4396.
39. Ranjith-Kumar C.T., Miller W., Sun J., Xiong J., Santos J., Yarbrough I., et al. Effects of single nucleotide polymorphisms on Toll-like receptor 3 activity and expression in cultured cells. J Biol Chem 2007, 282(24):17696-17705.
40. Biron C.A., Nguyen K.B., Pien G.C., Cousens L.P., Salazar-Mather T.P. Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu Rev Immunol 1999, 17:189-220.
41. Guidotti L.G., Chisari F.V. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu Rev Immunol 2001, 19:65-91.
42. Ikegame S., Takeda M., Ohno S., Nakatsu Y., Nakanishi Y., Yanagi Y. Both RIG-I and MDA5 RNA helicases contribute to the induction of alpha/beta interferon in measles virus-infected human cells. J Virol 2010, 84(1):372-379.
43. Takaki H., Watanabe Y., Shingai M., Oshiumi H., Matsumoto M., Seya T. Strain-to-strain difference of V protein of measles virus affects MDA5-mediated IFN-β-inducing potential. Mol Immunol 2011, 48(4):497-504.
44. Perneger T.V. What's wrong with Bonferroni adjustments. BMJ 1998, 316:1236-1238.
45. Poland G.A., Ovsyannikova I.G., Jacobson R.M. Personalized vaccines: the emerging field of vaccinomics. Expert Opin Biol Ther 2008, 8(11):1659-1667.